Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

12.79
Delayed Data
As of 3:59pm ET
 -0.12 / -0.93%
Today’s Change
7.70
Today|||52-Week Range
15.20
+29.45%
Year-to-Date

Today’s Trading

Previous close12.91
Today’s open12.91
Day’s range12.51 - 13.00
Volume1,900,473
Average volume (3 months)1,349,855
Market cap$1.7B
Dividend yield--
Data as of 3:59pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)-224.00%
Earnings growth (this year)-22.52%
Earnings growth (next 5 years)+13.27%
Revenue growth (last year)+8.61%
P/E ratioNM
Price/Sales8.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...+0.58+1.08%
AVXSAveXis Inc+1.14+1.68%
BPMCBlueprint Medicines ...+0.29+0.73%
RDUSRadius Health Inc+2.31+6.61%
Data as of 3:59pm ET, 05/22/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$146.7M
Annual profit (last year)-$103.0M
Net profit margin-70.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts